You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

METΔex14 mutation

Showing 1 - 25 of 3,966
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

NSCLC Trial in Guangzhou (PLB1001)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 15, 2023

NSCLC Trial in Pittsburgh (Capmatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2023

NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University
Sep 19, 2023

Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

Completed
  • Metastatic Non-Small Cell Lung Cancer
  • East Hanover, New Jersey
    18 Novartis Investigative Sites in the US
Dec 29, 2022

Non-Small Cell Lung Carcinoma Trial (Capmatinib 150 mg, Capmatinib 200 mg)

Recruiting
  • Non-Small Cell Lung Carcinoma
  • Capmatinib 150 mg
  • Capmatinib 200 mg
  • Guwahati, Assam, India
  • +7 more
Dec 19, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer
  • San Francisco, California
    University of California San Francisco
Aug 15, 2022

NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

Recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Toripalimab
  • +3 more
  • Guanzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Apr 4, 2023

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)

Active, not recruiting
  • Advanced Cancer
  • +4 more
  • Saint Louis, Missouri
  • +3 more
Apr 4, 2022

Phospholamban R14del Mutation-related Cardiomyopathy Trial in Netherlands (Eplerenone)

Completed
  • Phospholamban R14del Mutation-related Cardiomyopathy
  • Sneek, Friesland, Netherlands
  • +3 more
Oct 15, 2021

NSCLC Trial in United States (capmatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • La Jolla, California
  • +7 more
Oct 5, 2022

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

Solid Tumor, MET Exon 14 Skipping Mutation, MET Amplification Trial in Korea, Republic of (Tepotinib)

Recruiting
  • Solid Tumor
  • +2 more
  • Hwasun, Chonnam, Korea, Republic of
  • +21 more
Nov 30, 2020

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,

Completed
Has Results
  • Neoplasms, Breast
  • +5 more
  • Tucson, Arizona
  • +103 more
Nov 2, 2021

Advanced Solid Tumor Trial in Guangzhou (YL-17231)

Recruiting
  • Advanced Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 5, 2023

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Cystic Fibrosis, Pulmonary Trial in Shanghai (Sweat Test)

Recruiting
  • Cystic Fibrosis, Pulmonary
  • Sweat Test
  • Shanghai, Shanghai, China
    Shanghai pulmonary hospital
Oct 31, 2022

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)

Not yet recruiting
  • Obesity, Child
  • sequencing of a panel of 14 genes in leptin melanocortin pathway
  • (no location specified)
Jul 3, 2023

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023

Amyloidosis, Hereditary Trial in Richmond (Registry)

Not yet recruiting
  • Amyloidosis, Hereditary
  • Registry
  • Richmond, Virginia
    Virginia Commonwealth University
Jul 25, 2023

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

Completed
  • Cystic Fibrosis
  • Tucson, Arizona
  • +83 more
Jan 20, 2023

NSCLC Trial in Shanghai (RC48-ADC, Pyrotinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Feb 16, 2023